Renascience Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Renascience Inc. made a loss over the last year. Renascience Inc. owes ¥0.02 for every ¥1 it owns. Renascience Inc. made a loss in the year to Mar 2026, after a profit the year before.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
LossRenascience Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.18The share price is 4.18 times Renascience Inc.'s book value per share, higher than 84% of Healthcare companies in Japan.
Market cap
¥13.5 BThe total market value of all of Renascience Inc.'s shares at today's price (share price × number of shares), smaller than 55% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥3.2 BWhat Renascience Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥235.22Net worth divided by the number of shares. The share price of ¥983.00 is 4.2 times this, which is the P/B above.
Return on equity (ROE)
-13.0%Renascience Inc. lost 13.0% of its shareholders' money over the last year, lower than 79% of Healthcare companies in Japan.
Owes vs Owns
0.02×Renascience Inc. owes ¥0.02 for every ¥1 it owns (low), lower than almost all Healthcare companies in Japan.
Dividend yield
NoneRenascience Inc. does not currently pay a dividend.
Revenue growth
-48%Revenue fell 48% in the year to Mar 2026, and shrank 12% a year on average over 3 years.
Profit growth
LossRenascience Inc. made a loss in the year to Mar 2026, after a profit the year before.
Profit margin
-439.5%Renascience Inc. lost ¥439 for every ¥100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Renascience Inc.: ¥13.5 B ÷ ¥3.2 B (30 Jun 2026) = 4.2.
What is Renascience Inc.'s return on equity?
Renascience Inc. lost 13.0% of its shareholders' money over the last year, lower than 79% of Healthcare companies in Japan.
How much does Renascience Inc. owe compared with what it owns?
Renascience Inc. owes ¥0.02 for every ¥1 it owns (low), lower than almost all Healthcare companies in Japan.
Does Renascience Inc. pay a dividend?
No. Renascience Inc. does not currently pay a dividend.
Is Renascience Inc.'s revenue growing?
Revenue fell 48% in the year to Mar 2026, and shrank 12% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.